Home    eJManager.com Add Your Journal   |    Follow on Twitter   |    Subscribe to List

Directory for Medical Articles
 

Open Access

Original Research

RMJ. 2016; 41(3): 339-341


Immunoprophylaxis in Rh Incompatibility

Sadia Fahim, Muntiha Sarosh, Nikhat Ahsan.

Abstract
Objective: To investigate the frequency of Rh–ive patients and effectiveness of Rh immunization, comparing antibody titer before and after immunization.
Methodology: This comparative cross sectional study was carried out at the Department of Obstetrics and Gynecology, Fatima Hospital, Baqai Medical University, Karachi, from January 2013 to June 2014. Fifty primigravid women with Rh –ve blood group and their husbands with Rh +ve blood group were included in the study. The antibody titer through indirect Coomb’s test was checked in all the patients at 28 weeks gestation. If –ve titers, AntiD 1500 IU for prophylaxis was given between 28-34 weeks. After delivery, if baby was Rh +ve, AntiD was given within 72 hrs. Antibody titer was again measured at 6 weeks postpartum.
Results: Out of 50 primigravidae, 68% were B –ve, 30% were A –ve and 2% were O –ve. At 28 wks, 78% showed 1:4 dilution, 22% showed 1:8 dilution and no one reached up to 1:16 dilution. Six weeks postnatally, when antibody titers were repeated, there was no significant increase in titer.
Conclusion: The antibody titers are independent of AntiD IgG and immunization did not affect the level of antibody titer. Anti D IgG is thus the only and most effective prophylaxis against the Rh incompatability disease.

Key words: Immunoprophylaxis, Anti D, Antibody titre, Rh incompatibility



Share this Article




ScopeMed Home
Follow ScopeMed on Twitter
Article Tools
Job Opportunities/Service Offers
eJManager OJMS
eJPort Journal Hosting
About ScopeMed
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Service of eJManager LLC Publishing for Scientific Publications. Copyright © ScopeMed® Information Services.
Scopemed Buttons